Fluoxetine API

Mechanism of Action

Selective Serotonin Reuptake Inhibitor (SSRI) – Fluoxetine blocks the serotonin transporter in presynaptic neurons, increasing serotonin levels in the synaptic cleft. This enhances mood and reduces symptoms of depression and anxiety

Indication

Major Depressive Disorder (MDD)
Obsessive-Compulsive Disorder (OCD)
Bulimia Nervosa
Panic Disorder
Premenstrual Dysphoric Disorder (PMDD)

Dr. Reddy's Expertise

Headquartered in Hyderabad, India, Dr. Reddy's Laboratories is one of the leading Active Pharmaceutical Ingredients (API) manufacturers and suppliers globally for Fluoxetine API. Dr. Reddy's API business is a preferred partner to pharma companies across the US, Europe, Brazil, Latin America, Japan, China, Korea, Middle East and other emerging markets.

Dr. Reddy's API business thrives on the deep technical strengths established over the last 30+ years in the development and manufacture of complex APIs such as steroids, peptides, complex long chain molecules and highly potent APIs (HPAPIs / oncology drugs). This expertise is complemented by our prowess in intellectual property and regulatory affairs which helps us consistently meet and exceed regulatory standards. Dr. Reddy's Fluoxetine API is the outcome of the extensive expertise in R&D, IP, and Regulatory.

A key component in helping our customers be first to market is a responsive supply chain. We achieve this by making sure that all our facilities are operating efficiently and to the latest standards of quality, safety, and productivity. A strong interconnect between business and factories allows for a quick reaction to dynamic market changes, so that we can avert shortages and meet sudden surges in demand.